Back

Screen-detected atrial fibrillation (AF) and 'micro-AF' after myocardial infarction in patients 70-82 years and risk of cardiovascular events in the OMEMI trial

29 August 2022 (16:15 - 16:40)
Organised by:
Congress Presentation Part of: Treatment of atrial fibrillation in patient with coronary artery disease Prevalence and Incidence of Atrial Fibrillation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Trygve Berge

Vestre Viken Hospital Trust, Baerum (Norway)

4 More presentations in this session

Presentation thumbnail
Causes of death in patients with atrial fibrillation and a recent acute coronary syndrome or percutaneous coronary intervention: Insights from the AUGUSTUS trial
Professor R. Lopes (Durham, US)
Abstract Slides
Presentation thumbnail
Factors associated with progression of atrial fibrillation and impact on all-cause mortality: an ancillary analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General
Doctor M. Vitolo (Modena, IT)
Abstract Slides
Presentation thumbnail
Determinants of post-operative atrial fibrillation in 1613 patients undergoing coronary artery bypass grafting in the Statin Therapy In Cardiac Surgery (STICS) trial
Doctor R. Wijesurendra (Oxford, GB)
Abstract Slides
Presentation thumbnail
Features of clinical complexity in european patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry
Doctor M. Proietti (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Treatment of atrial fibrillation in patient with coronary artery disease

The Event

Event poster

ESC Congress 2022

29 August 2022 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Screening for atrial fibrillation to prevent stroke in elderly individuals with or without preexisting cardiovascular disease
26 August 2022
thumbnail
Congress Presentation
Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial
27 August 2021
thumbnail
Congress Presentation
One-year recurrence rate of new onset atrial fibrillation after an acute myocardial infarction.
14 March 2025
thumbnail
Congress Presentation
The effect of arrhyhthmia monitoring in post-MI patients: post-hoc analyses of the BIO-GUARD-MI trial
14 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources